Does Age Have a Differential Effect on 1 Month Versus 3 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding Risk?

Elkaryoni, Ahmed; Garg, Aakash; Abbott, J Dawn

Elkaryoni, Ahmed; Garg, Aakash; Abbott, J Dawn.

Affiliation

Elkaryoni A; Division of Cardiovascular Disease, Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island.
Garg A; Division of Cardiology, Ellis Hospital, Schenectady, New York.
Abbott JD; Division of Cardiovascular Disease, Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island. Electronic address: jabbott@lifespan.org.

Am J Cardiol ; 215: 96-97, 2024 Mar 15.

Article in En | MEDLINE | ID: mdl-38307175

Subject(s)

Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Humans; Infant; Platelet Aggregation Inhibitors/therapeutic use; Health Services

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Percutaneous Coronary Intervention Type of study: Etiology_studies / Risk_factors_studies Limits: Humans / Infant Language: En Journal: Am J Cardiol Year: 2024 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google